Publications

Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ- derived CD47 blocker

 57
Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ- derived CD47 blocker

Tags:

Previous Article

Broadly neutralizing antibodies against emerging delta-coronaviruses

Next Article

Immunotherapy for glioblastoma and its microenvironment

Related Posts

Oligodendrocytes drive neuroinflammation and neurodegeneration in Parkinson’s disease via the prosaposin-GPR37-IL-6 axis

Oligodendrocytes drive neuroinflammation and neurodegen...

 49

Microglia depletion reduces human neuronal APOE4-related pathologies in a chimeric Alzheimer’s disease model

Microglia depletion reduces human neuronal APOE4-relate...

 70

Transplacental SARS-CoV-2 protein ORF8 binds to complement C1q to trigger fetal inflammation

Transplacental SARS-CoV-2 protein ORF8 binds to complem...

 44